Oscar Health Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Oscar Health stock have an average target of 20.21, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 65.38% from the current stock price of 12.22.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$12	$20.21	$21	$28
Change	-1.80%	+65.38%	+71.85%	+129.13%

* Price targets were last updated on Mar 13, 2025.

Analyst Ratings

The average analyst rating for Oscar Health stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	0	0	0	0	0
Buy	4	4	4	4	3	2
Hold	2	2	2	2	3	3
Sell	1	2	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	7	8	8	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Baxter Wells Fargo	Wells Fargo	Buy → Hold Downgrades $20 → $16	Buy → Hold	Downgrades	$20 → $16	+30.93%	Mar 13, 2025
David Windley Jefferies	Jefferies	Sell Initiates $12	Sell	Initiates	$12	-1.80%	Dec 10, 2024
Adam Ron B of A Securities	B of A Securities	Hold → Sell Downgrades $21 → $14	Hold → Sell	Downgrades	$21 → $14	+10.47%	Nov 6, 2024
Jonathan Yong UBS	UBS	Hold Initiates $23	Hold	Initiates	$23	+88.22%	Oct 7, 2024
Jessica Tassan Piper Sandler	Piper Sandler	Buy Reiterates $28	Buy	Reiterates	$28	+129.13%	Sep 10, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

11.40B

from 9.18B

24.21%

from 9.18B

Revenue Next Year

11.46B

from 11.40B

0.55%

from 11.40B

EPS This Year

0.74

from 0.10

642.05%

from 0.10

EPS Next Year

1.02

from 0.74

37.97%

from 0.74

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	390.99M	1.89B	3.96B	5.86B	9.18B	11.40B	11.46B	13.76B
Revenue Growth	-17.79%	384.43%	109.27%	47.92%	56.54%	24.21%	0.55%	20.07%
EPS	-14.16	-3.20	-2.85	-1.22	0.10	0.74	1.02	1.82
EPS Growth	-	-	-	-	-	642.05%	37.97%	77.67%
Forward PE	-	-	-	-	-	16.47	11.94	6.72
No. Analysts	-	-	-	-	-	10	10	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	11.9B	13.3B	15.1B
Avg	11.4B	11.5B	13.8B
Low	10.4B	9.8B	11.0B

Revenue Growth

Revenue Growth	2025	2026	2027
High	29.2%	16.4%	32.0%
Avg	24.2%	0.6%	20.1%
Low	13.1%	-14.0%	-3.9%

EPS Forecast

EPS	2025	2026	2027
High	0.92	1.94	2.49
Avg	0.74	1.02	1.82
Low	0.59	0.39	1.17

EPS Growth

EPS Growth	2025	2026	2027
High	824.0%	161.8%	143.1%
Avg	642.1%	38.0%	77.7%
Low	488.0%	-47.2%	13.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.